Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients.

Lauren L PalazzoDeirdre F SheehanAngela C TramontanoChung Yin Kong

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

Attention to reducing disparities is needed as precision cancer treatments continue to be developed.

Keyphrases

squamous cell carcinoma
small cell lung cancer
single cell
working memory
cell therapy
affordable care act
advanced non small cell lung cancer
squamous cell
stem cells
bone marrow
health insurance